TIMP-1 is one of the tissue inhibitors of matrix metalloproteinases (MMP), the expression of which was previously linked with worse prognoses in melanoma [92], multiple myeloma [93], and breast cancer [94]. Here, TIMP1 is linked to AL amyloidosis.